Adage Capital Partners’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Adage Capital Partners’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.46M	Hold	1,000,000	–	–	﹤0.01%	824
2025 Q4	$3.98M	Sell	1,000,000 -2,338,034	-70%	-$10.3M	0.01%	785
2025 Q3	$12.6M	Buy	+3,338,034	New	+$11.3M	0.02%	587
2022 Q3	–	Sell	-900,000	Closed	-$10.2M	–	1076
2022 Q2	$10.2M	Sell	900,000 -500,000	-36%	-$5.99M	0.02%	664
2022 Q1	$22.7M	Hold	1,400,000	–	–	0.04%	416
2021 Q4	$66.3M	Buy	1,400,000 +200,094	+17%	+$12M	0.12%	172
2021 Q3	$87M	Buy	1,199,906 +375,000	+45%	+$27.1M	0.17%	127
2021 Q2	$69.3M	Sell	824,906 -391,788	-32%	-$25.8M	0.14%	161
2021 Q1	$59M	Sell	1,216,694 -187,606	-13%	-$10.2M	0.12%	184
2020 Q4	$66.2M	Buy	1,404,300 +224,228	+19%	+$8.83M	0.14%	157
2020 Q3	$55.5M	Buy	1,180,072 +62,755	+6%	+$2.07M	0.14%	164
2020 Q2	$33.4M	Buy	1,117,317 +117,317	+12%	+$2.43M	0.09%	263
2020 Q1	$13M	Buy	+1,000,000	New	+$12.5M	0.04%	415

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Adage Capital Partners's NBP Position: Q1 2026 in Review

Adage Capital Partners held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q1 2026 at 1,000,000 shares worth $2.46M. The position accounts for ﹤0.01% of the portfolio, ranked #824.

Adage Capital Partners first reported a position in NBP in Q1 2020 and has held it in 13 quarters since. The position peaked at $87M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

Adage Capital Partners held 1,000,000 shares of NovaBridge Biosciences American Depositary Shares worth $2.46M as of Q1 2026.
Adage Capital Partners left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q1 2026.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Adage Capital Partners's portfolio in Q1 2026, its #824 holding.
Adage Capital Partners first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2020 and has held it in 13 quarters since.
Adage Capital Partners's NovaBridge Biosciences American Depositary Shares position peaked at $87M in Q3 2021.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.